Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Total Current Liabilities (2023 - 2025)

Historic Total Current Liabilities for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $29.6 million.

  • Metagenomi's Total Current Liabilities fell 3525.56% to $29.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.6 million, marking a year-over-year decrease of 3525.56%. This contributed to the annual value of $37.3 million for FY2024, which is 4581.98% down from last year.
  • Metagenomi's Total Current Liabilities amounted to $29.6 million in Q3 2025, which was down 3525.56% from $33.3 million recorded in Q2 2025.
  • In the past 5 years, Metagenomi's Total Current Liabilities ranged from a high of $70.7 million in Q1 2024 and a low of $29.6 million during Q3 2025
  • Moreover, its 3-year median value for Total Current Liabilities was $42.8 million (2024), whereas its average is $47.3 million.
  • In the last 5 years, Metagenomi's Total Current Liabilities tumbled by 4581.98% in 2024 and then tumbled by 3525.56% in 2025.
  • Quarter analysis of 3 years shows Metagenomi's Total Current Liabilities stood at $68.9 million in 2023, then plummeted by 45.82% to $37.3 million in 2024, then dropped by 20.71% to $29.6 million in 2025.
  • Its Total Current Liabilities stands at $29.6 million for Q3 2025, versus $33.3 million for Q2 2025 and $39.9 million for Q1 2025.